| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children.
|
J Pediatr
|
1974
|
3.09
|
|
2
|
Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
|
N Engl J Med
|
1998
|
3.05
|
|
3
|
Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group.
|
J Allergy Clin Immunol
|
1994
|
2.34
|
|
4
|
Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.
|
Ann Intern Med
|
2000
|
2.30
|
|
5
|
Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma.
|
J Pediatr
|
1998
|
1.52
|
|
6
|
The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children.
|
J Pediatr
|
1999
|
1.47
|
|
7
|
Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group.
|
J Pediatr
|
1998
|
1.32
|
|
8
|
Clinical value of bronchial provocation testing in childhood asthma.
|
J Allergy Clin Immunol
|
1977
|
1.16
|
|
9
|
Inhibition of antibody production and acquired immunologic tolerance by actinomycin.
|
J Immunol
|
1965
|
1.12
|
|
10
|
Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.
|
Pediatrics
|
2000
|
1.08
|
|
11
|
Inhalation bronchial challenge testing in asthmatic children.
|
Pediatr Clin North Am
|
1969
|
1.01
|
|
12
|
A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology.
|
J Allergy Clin Immunol
|
1990
|
0.97
|
|
13
|
Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis.
|
Ann Allergy
|
1989
|
0.95
|
|
14
|
Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial.
|
J Am Acad Dermatol
|
1995
|
0.90
|
|
15
|
Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
|
J Allergy Clin Immunol
|
2000
|
0.89
|
|
16
|
Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis.
|
Pediatrics
|
1993
|
0.87
|
|
17
|
A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis.
|
J Allergy Clin Immunol
|
1999
|
0.84
|
|
18
|
Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis.
|
Ann Allergy
|
1991
|
0.83
|
|
19
|
Production of tolerance in immunized mice and the effects of immunosuppression.
|
J Allergy
|
1966
|
0.82
|
|
20
|
Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma.
|
Ann Allergy Asthma Immunol
|
1998
|
0.82
|
|
21
|
Albuterol treatment for children with asthma: a comparison of inhaled powder and aerosol.
|
J Allergy Clin Immunol
|
1989
|
0.80
|
|
22
|
A one-week dose-ranging study of inhaled salmeterol in children with asthma.
|
J Asthma
|
1997
|
0.80
|
|
23
|
Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology.
|
J Allergy Clin Immunol
|
1992
|
0.79
|
|
24
|
Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications.
|
J Allergy Clin Immunol
|
1995
|
0.78
|
|
25
|
Comparison of the bronchodilator effects of nebulized bitolterol mesylate and isoproterenol hydrochloride in steroid-dependent asthma.
|
J Allergy Clin Immunol
|
1987
|
0.77
|
|
26
|
Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate.
|
J Allergy Clin Immunol
|
1993
|
0.76
|
|
27
|
A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis.
|
J Allergy Clin Immunol
|
1995
|
0.76
|
|
28
|
Corticosteroid-sparing effect of azelastine in the management of bronchial asthma.
|
Am J Respir Crit Care Med
|
1996
|
0.76
|
|
29
|
Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis.
|
Am J Ther
|
1998
|
0.75
|
|
30
|
Clinical evaluation of triamcinolone acetonide nasal aerosol in children with perennial allergic rhinitis.
|
Ann Allergy
|
1991
|
0.75
|
|
31
|
Physician/patient acceptability and efficacy study of Quibron-T/SR tablets in adult asthmatics.
|
J Asthma
|
1982
|
0.75
|
|
32
|
Acceptability and efficacy of a new theophylline dosage form: Quibron-T.
|
J Asthma
|
1982
|
0.75
|
|
33
|
The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control.
|
J Allergy Clin Immunol
|
1997
|
0.75
|
|
34
|
Multicenter dose-ranging study of bitolterol mesylate solution for nebulization in children with asthma.
|
Ann Allergy
|
1994
|
0.75
|